These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 26165502)

  • 1. Fungal infections in the ICU: advances in treatment and diagnosis.
    De Pascale G; Tumbarello M
    Curr Opin Crit Care; 2015 Oct; 21(5):421-9. PubMed ID: 26165502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
    Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
    Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.
    Mikolajewska A; Schwartz S; Ruhnke M
    Mycoses; 2012 Jan; 55(1):2-16. PubMed ID: 21554421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive mould infections in the ICU setting: complexities and solutions.
    Bassetti M; Bouza E
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU.
    Coyle EA
    J Pharm Pract; 2010 Feb; 23(1):33-7. PubMed ID: 21507791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
    Bassetti M; Garnacho-Montero J; Calandra T; Kullberg B; Dimopoulos G; Azoulay E; Chakrabarti A; Kett D; Leon C; Ostrosky-Zeichner L; Sanguinetti M; Timsit JF; Richardson MD; Shorr A; Cornely OA
    Intensive Care Med; 2017 Sep; 43(9):1225-1238. PubMed ID: 28255613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micafungin use in children.
    Emiroglu M
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
    Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
    Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
    Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
    Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
    Epico Project Group
    Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
    Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
    Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review.
    Azim A; Ahmed A
    Front Cell Infect Microbiol; 2024; 14():1256158. PubMed ID: 38505289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal infections after lung transplantation.
    Solé A; Salavert M
    Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of Fungal Infections--The Italian Experience.
    Bassetti M; Righi E
    Semin Respir Crit Care Med; 2015 Oct; 36(5):796-805. PubMed ID: 26398544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.
    Trof RJ; Beishuizen A; Debets-Ossenkopp YJ; Girbes AR; Groeneveld AB
    Intensive Care Med; 2007 Oct; 33(10):1694-703. PubMed ID: 17646966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole: when and how? The clinician's view.
    Katragkou A; Tsikopoulou F; Roilides E; Zaoutis TE
    Mycoses; 2012 Mar; 55(2):110-22. PubMed ID: 21762211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
    Schmiedel Y; Zimmerli S
    Swiss Med Wkly; 2016; 146():w14281. PubMed ID: 26901377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungals in the ICU.
    Playford EG; Eggimann P; Calandra T
    Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on antifungal treatment of invasive Candida and Aspergillus infections.
    Maschmeyer G; Ruhnke M
    Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.